The abstract is read at the publisher; the summary is JClub's.
Pharmacologic activation of the IRE1 arm of the unfolded protein response selectively reduces TH17 differentiation by limiting intracellular cholesterol in differentiating TH17 cells.
- Why it matters: TH17 dysregulation fuels chronic inflammatory and autoimmune diseases, but targeted ways to restrain TH17 differentiation without broadly affecting other helper T cell fates are needed.
- What they did: The study pharmacologically activated IRE1 and assessed helper T cell differentiation, then linked the effect to increased degradation of the cholesterol biosynthesis enzyme HMGCR.
- The result: IRE1 activation rewires cholesterol metabolism in differentiating TH17 cells via HMGCR degradation, suppressing TH17 differentiation while leaving other helper subsets unaffected, suggesting a therapeutic strategy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.